Formulating a Gene Signature for Diagnosis of Autoimmune and Infectious Diseases
ISEF · 2021 Translational Medical Science
Overview
Many infectious and autoimmune diseases are difficult to diagnose properly, and the current diagnostic tests for these diseases are either pathogen/antibody specific, or have a slow turnaround time. A drug for one disease may harm another, so I am working with the Khatri Lab at Stanford to create a gene signature to accurately diagnose these diseases. We collected and curated the blood transcriptome profiles from 23,572 patients with 7,532 genes across 224 independent cohorts from over 50 countries and sorted them into 23 major disease groups. We used a co-normalization method called COCONUT to merge the data, using the healthy samples in each dataset as a common baseline. After trying machine learning models such as Random Forest and SVM, I used MANATEE’s statistical analysis to create my gene signature. MANATEE avoids overfitting to the training data by starting with a small number of genes and using a greedy algorithm to add or subtract genes to maximize the AUC. I created two signatures to differentiate autoimmune/infectious from healthy samples and to differentiate autoimmune from infectious samples. My model achieves a ROC AUC of over 0.87 on validation datasets. Because my data includes heterogeneity across countries, specific disease, and more, my gene signature can be used in almost any clinical population, including both developing and western countries, as a blood test screening tool. In the future, I would like to translate my signature into clinical practice following wet lab confirmation and expand it to more disease groups.
Competition history
- ISEF 2021
Resources
Related projects
ISEF · 2023
Advancing Autoimmune Disease Treatment With AI-Assisted Gene Expression Analysis
ISEF · 2025
Discovery of Novel Self-Antigens in IgG4-Related Disease Using Computational Modeling and Human Proteome Screening
ISEF · 2021
Apply Machine Learning to Identify Unique Patient Clusters and Associated Key Biomarkers in Rheumatoid Arthritis Developing a Point of Care Test with a Multi Biomarker Panel for RA Patient Classification and Disease Progression
ISEF · 2024
Genetic Analysis of CD16+ Monocyte, CD16- Monocyte and CD4+ T Lymphocyte Cells to Identify Novel Gene Expression Signatures and Develop a Diagnostic Tool for Systemic Lupus Erythematosus
Closest projects by meaning, across every fair and year in the corpus.
Source: Regeneron International Science and Engineering Fair